Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Genomic Approaches to Hypertension. Cardiol Clin 2017 May;35(2):185-196

Date

04/17/2017

Pubmed ID

28411893

DOI

10.1016/j.ccl.2016.12.001

Scopus ID

2-s2.0-85017435059   4 Citations

Abstract

Genomic insights and analyses of Mendelian hypertension (HTN) syndromes and Genome-Wide Association study (GWAS) on essential hypertension have contributed to the depth of understanding of the genetics origins of hypertension. Mendelian syndromes are important for the field, since such knowledge leads to specific insights about disease pathogenesis and the potential for precision medicine. The clinical impact of findings of on essential hypertension is continuously evolving, and the insights accrued will refine efforts to combat the societal impact of hypertension. Comprehensive identification of all genomic variants of hypertension, along with their individual associated mechanisms, is paving the way forward in the era of personalized medicine. The overriding challenge for care providers is to reduce health inequities through improved compliance and, perhaps, new paradigms for implementation science that incorporate genomic medicine.

Author List

Dodoo SN, Benjamin IJ

Author

Ivor J. Benjamin MD Center Director, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Genome-Wide Association Study
Genomics
Humans
Hypertension
jenkins-FCD Prod-482 91ad8a360b6da540234915ea01ff80e38bfdb40a